Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126355031 | 12635503 | 1 | I | 20141020 | 20160727 | 20160809 | 20160809 | EXP | CA-HQ SPECIALTY-CA-2016INT000734 | INTERCHEM | 61.00 | YR | F | Y | 0.00000 | 20160809 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126355031 | 12635503 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | (10 DOSAGE FORM,1 IN 1 W) | 201749 | 10 | DF | ||||||||
| 126355031 | 12635503 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | 201749 | |||||||||||
| 126355031 | 12635503 | 3 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG, (5 MG,2 IN 1 D) | Y | 0 | 10 | MG | |||||||
| 126355031 | 12635503 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | 10 MG (2X5 MG) ONCE DAILY (AS NECESSARY) | 0 | |||||||||||
| 126355031 | 12635503 | 5 | SS | CELEBREX | CELECOXIB | 1 | Oral | 2 DOSAGE FORM (1 DOSAGE FORM, 2 IN 1 D) | 0 | 1 | DF | ||||||||
| 126355031 | 12635503 | 6 | C | RANITIDINE. | RANITIDINE | 1 | (2 IN 1 D) | U | 0 | ||||||||||
| 126355031 | 12635503 | 7 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 50 MG, 1 AT BED TIME | U | 0 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126355031 | 12635503 | 1 | Rheumatoid arthritis |
| 126355031 | 12635503 | 3 | Rheumatoid arthritis |
| 126355031 | 12635503 | 4 | Rheumatoid arthritis |
| 126355031 | 12635503 | 5 | Rheumatoid arthritis |
| 126355031 | 12635503 | 6 | Product used for unknown indication |
| 126355031 | 12635503 | 7 | Fibromyalgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126355031 | 12635503 | OT |
| 126355031 | 12635503 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126355031 | 12635503 | Bronchitis | |
| 126355031 | 12635503 | Headache | |
| 126355031 | 12635503 | Pneumonia | |
| 126355031 | 12635503 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126355031 | 12635503 | 3 | 20141014 | 201606 | 0 | |
| 126355031 | 12635503 | 4 | 1995 | 0 | ||
| 126355031 | 12635503 | 5 | 2000 | 0 | ||
| 126355031 | 12635503 | 6 | 2000 | 0 | ||
| 126355031 | 12635503 | 7 | 1995 | 0 |